Clinical Trials Logo

Obstructive Sleep Apnea clinical trials

View clinical trials related to Obstructive Sleep Apnea.

Filter by:

NCT ID: NCT01742949 Completed - Clinical trials for Obstructive Sleep Apnea

Study to Predict the Benefits of First-line Humidification Use and Comparison of the Effect of ThermoSmartâ„¢ and no Humidification on Adherence

Start date: October 2013
Phase: N/A
Study type: Interventional

This study aims to investigate the benefits of using first line heated humidification. The primary objective of this research is to determine the effect of high levels of humidification delivered by ThermoSmartâ„¢ on CPAP adherence. In addition, to determine if it is possible to predict which patients benefit the most (i.e. be more adherent with therapy) from high levels of humidification delivered by ThermoSmart.

NCT ID: NCT01741480 Completed - Cancer Clinical Trials

Early Warning System

Start date: February 2013
Phase: N/A
Study type: Interventional

The study will begin in 2013 whereby patients having an early warning system (EWS) alert will be randomized to be seen by the rapid response team (RRT) for triage versus usual care. A RRT is usually made up of a nurse and/or a physician who respond to a requested activation of the RRT (called an "ACT"). The intervention will occur as follows:

NCT ID: NCT01728974 Completed - Clinical trials for Obstructive Sleep Apnea

Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study A

Start date: December 8, 2012
Phase: N/A
Study type: Interventional

In obstructive sleep apnea, the upper airway recurrently closes during sleep. The mechanisms that lead to airway closure are not completely understood. While the airway of some people narrows and airflow decreases during inspiration due to increasing inspiratory effort, others maintain constant airflow throughout inspiration. Airway neuromuscular reflexes may protect against airway narrowing that occurs due to increasing inspiratory effort. To test this hypothesis, the investigators will initially measure airway neuromuscular reflex and inspiratory flow and then attenuate neuromuscular reflex through topical pharyngeal anesthesia to observe the effects on inspiratory flow.

NCT ID: NCT01703663 Completed - Clinical trials for Obstructive Sleep Apnea

Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.

Start date: November 2012
Phase: Phase 2
Study type: Interventional

Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke. Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night. Hypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation with nasal EPAP therapy compared with a control night.

NCT ID: NCT01697878 Completed - Obesity Clinical Trials

Consequences of Obstructive Sleep Apnea on Respiratory Function Following Weight-loss Surgery

Start date: March 2012
Phase: N/A
Study type: Interventional

The investigators propose to compare two different treatments, continuous positive airway pressure (CPAP) versus breathing of atmospheric pressure, in subjects with obstructive sleep apnea (OSA)recovering from weight loss surgery in the post anesthesia care unit (PACU). WE hypothesize that subjects with OSA will have a higher Apnea-Hypopnea Index (AHI) with desaturation and the investigators expect that post-operative CPAP treatment in the PACU will significantly improve the AHI and therefore improve patient safety in the PACU. The investigators also hypothesize that subjects with OSA have a greater decrease in oxygen saturation in response to opioid administration by patient-controlled opioid analgesia (PCA).

NCT ID: NCT01690429 Completed - Clinical trials for Obstructive Sleep Apnea

Arousal Analysis by Pulse Wave Amplitude in Patients With Obstructive Sleep Apnea

Start date: June 2012
Phase: N/A
Study type: Interventional

Photoplethysmography is an easy non-invasive method to detect the pulse wave amplitude (PWA) from a finger. This can be measured using the Somnocheck micro system. A pulse wave amplitude decrease (PWAD) is considered to be a marker for autonomic activation. Detecting the PWAD is a surrogate marker for waking reactions (arousal) which eventually will contribute to assess sleep disruption and resulting performance deterioration. Arousal and performance deterioration and its possible improvement under continuous positive airway pressure (CPAP) therapy will be determined in this study.

NCT ID: NCT01672502 Completed - Clinical trials for Obstructive Sleep Apnea

Fire Fighter Fatigue Management Program: Operation Fight Fatigue

Start date: September 2012
Phase: N/A
Study type: Interventional

Firefighters frequently work extended duration shifts and long work weeks which have adverse effects on alertness, health, safety and performance. This protocol uses a survey instrument to examine the effects of extended duration shifts on safety outcomes (e.g., motor vehicle crashes, accidents, injuries), health (e.g., diagnosis and treatment of sleep disorders, improved general health indices, decreased number of sick days), and performance (e.g., decreased response time). This study will expand understanding of the nature, scope, etiology and consequences of firefighter fatigue and increase our ability to develop guidelines that can be generalized across fire departments throughout North America. This study could provide an avenue to make lasting policy improvements that could enhance the safety, health, and performance of firefighters.

NCT ID: NCT01637831 Completed - Clinical trials for Obstructive Sleep Apnea

CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Sleep Apnea

Start date: March 2010
Phase: N/A
Study type: Interventional

The recent literature shows an increased incidence of obstructive sleep apnea (OSA) in patients with idiopathic pulmonary fibrosis (IPF). On the other hand there are no published studies related to CPAP treatment in this patient group. The investigators aim was to assess the effect of CPAP on sleep and overall life quality parameters in IPF patients with OSA and to recognize and overcome possible difficulties in CPAP initiation and acceptance by these patients.

NCT ID: NCT01635010 Completed - Clinical trials for Obstructive Sleep Apnea

Obstructive Sleep Apnea in the Absence of Metabolic Syndrome

Start date: December 2008
Phase: Phase 4
Study type: Interventional

Obstructive Sleep Apnea (OSA) is commonly associated with factors that increase cardiovascular risk, including Metabolic Syndrome (MS). There is a lack of well-controlled clinical studies investigating the independent effects of OSA in the development of cardiovascular disease, especially evaluating jointly mechanisms involved in these disorders such as inflammatory response, oxidative stress and vascular changes. The investigators hypothesized that in the absence of MetS, the mechanisms involved on cardiovascular consequences in OSA patients would be less important. The purpose of this study is to analyze the effects of OSA in the absence of MS, on inflammatory, oxidative stress and vascular markers; to verify the influence of excessive daytime sleepiness (EDS) on the same parameters; and additionally verify the effects of nasal continuous positive airway pressure (nCPAP)in theses parameters.

NCT ID: NCT01600066 Completed - Clinical trials for Obstructive Sleep Apnea

Erectile Dysfunction in Severe Obstructive Sleep Apnea: Effects of CPAP Therapy

Start date: May 2012
Phase: N/A
Study type: Observational

Obstructive sleep apnea has been linked to erectile dysfunction. Furthermore, small studies suggest that treatment of sleep apnea by continuous positive airway pressure (CPAP) may reverse erectile dysfunction in affected patients. The present study aims to investigate in a larger cohort if severe sleep apnea is independently associated with erectile dysfunction and if 6-12 months of CPAP therapy lead to an improvement of erectile dysfunction.